Search
for
Sort by
Research 31–60 of 265
- Was the epidemic skin disease of 1891 due to acute arsenic poisoning?
- Dermatoses of pregnancy
- Long COVID syndrome: An unfolding enigma
- Finasteride-induced gynecomastia
- Generalized pruritus in primary sclerosing cholangitis: implications of histamine release by lysophosphatidic acid
- Natural Killer Group 2 Type D (NKG2D) Gene Polymorphism in Systemic Lupus Erythematosus-Suez Canal Region - Egypt
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Severe cutaneous adverse reactions to drugs
- Drug-Induced Skin, Nail and Hair Disorders
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- The role of lymphocytes in the development and treatment of alopecia areata
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Gender aspects in skin diseases
- To grow or not to grow: Hair morphogenesis and human genetic hair disorders
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Whole-Cell Bioprocessing of Human Fetal Cells for Tissue Engineering of Skin
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Skin disease in pregnancy
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Acne in women
- MicroRNA in skin diseases
- Idiopathic CD4+ T-lymphocytopenia
- Accelerated Endothelial to Mesenchymal Transition Increased Fibrosis via Deleting Notch Signaling in Wound Vasculature
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Skin disease in pregnancy
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias
- Newborn infant skin gene expression: Remarkable differences versus adults
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites